SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
Kaori Sano, Disha Bhavsar, Gagandeep Singh et al. · Nature Communications · 2022
Full textCC BY
Infectious Diseases
Filters2 filters applied
Status
- Expression of concern
- Corrected
- No notice
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Year
Readable here
Study type
Licence
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
Jasmin Quandt, Alexander Muik, Nadine Salisch et al. · Science Immunology · 2022
Full textCC BY
Antibody evasion properties of SARS-CoV-2 Omicron sublineages
Sho Iketani, Lihong Liu, Yicheng Guo et al. · Nature · 2022
Full textCC BY
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
Dami A. Collier, Isabella A. T. M. Ferreira, Prasanti Kotagiri et al. · Nature · 2021
Full textCC BY
Community-based active case-finding interventions for tuberculosis: a systematic review
Rachael M Burke, Marriott Nliwasa, Helena R A Feasey et al. · The Lancet Public Health · 2021 · Systematic review
Full textCC BY
Corrected Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
Philippe Bégin, Jeannie Callum, Erin Jamula et al. · Nature Medicine · 2021 · Randomised trial
Full textCC BY
Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis
Paddy Ssentongo, Emily S. Heilbrunn, Anna E. Ssentongo et al. · Scientific Reports · 2021 · Meta-analysis
Full textCC BY
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
Teny M. John, Ceena N. Jacob, Dimitrios P. Kontoyiannis · Journal of Fungi · 2021 · Review
Full textCC BY
Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020
Kathy Leung, Marcus HH Shum, Gabriel M Leung et al. · Eurosurveillance · 2021
Full textCC BY
SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis
Ji-Seung Yoo, Michihito Sasaki, Steven X. Cho et al. · Nature Communications · 2021
Full textCC BY
Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID‐19 mRNA vaccine
Mikiko Watanabe, Angela Balena, Dario Tuccinardi et al. · Diabetes/Metabolism Research and Reviews · 2021
Full textCC BY
COVID-19 ICU and mechanical ventilation patient characteristics and outcomes—A systematic review and meta-analysis
Raymond Chang, Khaled Mossad Elhusseiny, Yu-Chang Yeh et al. · PLOS ONE · 2021 · Meta-analysis
Full textCC BY
Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants
Sebastian Weigang, Jonas Fuchs, Gert Zimmer et al. · Nature Communications · 2021 · Case report
Full textCC BY
The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic
Priyanka Shah, Gabriela A. Canziani, Erik P. Carter et al. · Frontiers in Immunology · 2021
Full textCC BY
Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation
Florence WJ Chioh, Siew-Wai Fong, Barnaby E Young et al. · eLife · 2021
Full textCC BY
SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation
David W Sanders, Chanelle C Jumper, Paul J Ackerman et al. · eLife · 2021
Full textCC BY
SARS-CoV-2: from its discovery to genome structure, transcription, and replication
Ayslan Castro Brant, Wei Tian, Vladimir Majerciak et al. · Cell & Bioscience · 2021 · Review
Full textCC BY
Epidemiology of Mucormycosis in India
Hariprasath Prakash, Arunaloke Chakrabarti · Microorganisms · 2021 · Review
Full textCC BY
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival
Stefania Dispinseri, Massimiliano Secchi, Maria Franca Pirillo et al. · Nature Communications · 2021
Full textCC BY
Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice
Pratima Kumari, Hussin A. Rothan, Janhavi P. Natekar et al. · Viruses · 2021
Full textCC BY